Eyepoint pharmaceuticals appoints esteemed industry leader fred hassan to board of directors

- appointment strengthens leadership team as company approaches dosing of patients in phase 3 pivotal trials of duravyu™ in wet amd in 2024 - - appointment strengthens leadership team as company approaches dosing of patients in phase 3 pivotal trials of duravyu™ in wet amd in 2024 -
AMD Ratings Summary
AMD Quant Ranking